ROCHE HOLDING LTD 4
4 · Jasper Therapeutics, Inc. · Filed Jan 26, 2023
Insider Transaction Report
Form 4
ROCHE HOLDING LTD
10% Owner
Transactions
- Sale
Voting Common Stock
2023-01-25$1.89/sh−75,000$141,750→ 4,549,606 total(indirect: See Footnote)
Footnotes (1)
- [F1]Represents shares held by Roche Finance Ltd ("Roche Finance"). Roche Finance is a wholly owned subsidiary of Roche Holding Ltd ("Roche Holding"), a Swiss corporation whose shares are traded on the SIX Swiss Exchange. Roche Holding is the indirect beneficial owner of these securities of the Issuer. This Form 4 shall not be deemed an admission that any reporting person or other person is a beneficial owner of any securities of the Issuer for any purpose, other than the securities reported in this Form 4.